XML 47 R36.htm IDEA: XBRL DOCUMENT v3.24.0.1
INCOME TAXES (Tables)
9 Months Ended
Dec. 31, 2023
Notes and other explanatory information [abstract]  
Schedule of income tax benefit
          
   Nine Months Ended December 31,
(In thousands)  2023  2022
       
Current:          
Federal  $(15)  $(16)
State and local       (8)
Foreign        
Total current   (15)   (24)
           
Deferred:          
Federal        
State and local        
Foreign   10,564    2,930 
Total deferred   10,564    2,930 
Benefit from income taxes  $10,549   $2,906 
Schedule of reconciliation income tax rates
          
   Nine Months Ended December 31,
   2023  2022
Loss on ordinary activities before tax  $(1,712)  $(1,230)
Statutory U.S. income tax rate   21.0%   21.0%
Income tax benefit at statutory income tax rate   359    258 
Share-based compensation expense recognized for financial statement purposes   (419)    
Other losses (unrecognized)   (14)   (282)
Utilization of losses not previously benefitted   59     
Income tax (expense)  $(15)  $(24)
Schedule of effective income tax rates
          
   Nine Months Ended December 31,
   2023  2022
Loss on ordinary activities before tax  $(52,013)  $(4,567)
Statutory U.K. income tax rate   25.0%   19.0%
Loss at statutory income tax rate   13,003    868 
           
Change from increase in deferred income tax rate       274 
Derecognition of deferred tax assets   (2,451)    
Foreign currency effect   12    1,788 
Income tax benefit  $10,564   $2,930 
Schedule of reconciliation of financial statement income (loss)
                                        
   Nine Months Ended December 31,
   2023  2022
   United
States
  BVI  United
Kingdom
  Total  United
States
  BVI  United
Kingdom
  Total
                         
Pre-tax loss  $(1,712)  $(14,473)  $(52,570)  $(68,755)  $(1,230)  $(7,320)  $(4,567)  $(13,117)
Share-based compensation expense for financial statement purposes for which no benefit was taken   1,997            1,997                 
Loss for which no benefit was taken                   1,622            1,622 
Losses not subject to tax   65    14,473    557    15,095        7,320        7,320 
Utilization of losses not previously benefitted   (280)           (280)   (314)           (314)
Taxable income (loss)  $70   $   $(52,013)  $(51,943)  $78   $   $(4,567)  $(4,489)
Schedule of deferred tax assets and liabilities
          
   As of December 31,  As of March 31,
   2023  2023
Deferred tax assets:          
Net operating loss  $(5,500)  $(4,131)
Deferred tax asset (unrecognized)   3,951    1,500 
Deferred tax asset   (1,549)   (2,631)
           
Deferred tax liabilities:          
In-process research and development   1,549    13,195 
Deferred tax liability   1,549    13,195 
           
Net deferred tax liability  $   $10,564